These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11051251)

  • 1. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
    Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
    World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
    Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
    World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
    Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
    Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas.
    Jang KT; Chae SW; Sohn JH; Park HR; Shin HS
    J Korean Med Sci; 2002 Feb; 17(1):29-33. PubMed ID: 11850585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
    Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
    Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
    Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR
    J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
    Feng H; Ghazizadeh M; Konishi H; Araki T
    Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
    Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A
    Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
    Rakha EA; Boyce RW; Abd El-Rehim D; Kurien T; Green AR; Paish EC; Robertson JF; Ellis IO
    Mod Pathol; 2005 Oct; 18(10):1295-304. PubMed ID: 15976813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
    Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
    World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
    Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
    Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
    Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
    Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
    Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
    Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
    Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
    Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S; Sato E
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.